HIF1A and neoplasm: When tumor cells must cope with hypoxic conditions or with pseudohypoxia elicited by a rise in oncometabolite levels [69], stabilization of HIF1α and the consequent orchestration of the HIF1-dependent transcriptional program confer them increased motility, while favoring angiogenesis, decreasing OXPHOS and enhancing glucose usage [70].